Mycamine is now approved for the treatment of infants with candidemia, acute disseminated candidiasis, Candida peritonitis and abscesses, esophageal candidiasis, and prophylaxis of Candida infections ...
Invasive or systemic fungal infections are a frequent cause of morbidity and mortality in haemato-oncology patients undergoing intensive chemotherapy or haematopoietic stem cell transplantation (HSCT) ...
Astellas Pharma, Inc. ( ALPMY) recently announced the receipt of US Food and Drug Administration (FDA) approval for the expanded use of Mycamine injection in pediatric patients four months and older.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback